Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model.
Abdallah Mahmoud El-EbidiTahia H SaleemMohamed Gamal El-Din SaadiHala Abdallah MahmoudZeinab MohamedHoda S SherkawyPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
According to this animal study, we proved that CyPA is a valuable marker for DN. It is a more sensitive, noninvasive and rapid biomarker for early detection of any renal affection in human diabetic patients.